---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-314167"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2026-07-23T20:25:51+00:00"
generated_at: "2026-07-23T20:27:10.244034+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ImageneBio appoints Yanina Grant-Huerta as CFO; CMO Benjamin Porter-Brown transitions to consulting role

## Summary
- Yanina Grant-Huerta appointed CFO effective July 20, 2026; base salary $450,000, target bonus 40%, equity grants of 65,000 RSUs and 95,000 options.
- Benjamin Porter-Brown, CMO, will transition from full-time to consulting role effective July 24, 2026; will serve as strategic advisor.
- Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics (ATRA) from March 2025 to July 2026.
- Grant-Huerta's equity awards vest over four years; 25% on first anniversary, remainder monthly/quarterly.

## SEC filing metadata
- accession: 0001193125-26-314167
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2026-07-23T20:25:51+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/0001193125-26-314167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/d143178d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-314167
- JSON: https://secwatch.observer/filing/0001193125-26-314167.json
- Plain text: https://secwatch.observer/filing/0001193125-26-314167.txt

## Key facts
- Executive change
  Yanina Grant-Huerta was appointed as Chief Financial Officer at ImageneBio, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/0001193125-26-314167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.